BiotechTube
Home/Calico/Arthur D. Levinson, Ph.D.
AD

Arthur D. Levinson, Ph.D.

Founder & CEO

Calico

Therapeutic Areas

AgingPolycystic Kidney DiseaseVanishing White Matter DiseaseAge-related Diseases

Calico Pipeline

DrugIndicationPhase
Fosigotifator (ABBV-CLS-7262)Vanishing White Matter DiseasePhase 2
Undisclosed ProgramAutosomal Dominant Polycystic Kidney Disease (ADPKD)Phase 2

Leadership Team at Calico

JR
Joseph R. Arron, M.D., Ph.D.
Head of Human Biology and Genetics
PK
Philip Kym, Ph.D.
Head of Drug Discovery
View full Calico profile